Psychometric properties and validation of a four-item version of the Strauss–Carpenter scale in bipolar disorder

International Journal of Bipolar Disorders

Volumn 4, Issue 1, 2016, Pages

  Alberich, Susana ^a,b   Barbeito, Sara ^a,b,c   González Ortega, Itxaso ^a,b,d   Ugarte, Amaia ^a,b   Vega, Patricia ^a,b   de Azúa, Sonia Ruiz ^a,b,d   López, Purificación ^a,b,d   Zorrilla, Iñaki ^a,b,d   González Pinto, Ana ^a,b,d  

^a HOSPITAL TXAGORRITXU   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^c UNIVERSIDAD INTERNACIONAL DE LA RIOJA   (Spain)

^d UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Bipolar; Functioning; Outcome; Prognosis; Strauss Carpenter

Indexed keywords

ADULT; AGED; ARTICLE; BIPOLAR DISORDER; CHURG STRAUSS SYNDROME; CLINICAL GLOBAL IMPRESSION FOR BIPOLAR DISORDER THE MODIFIED VERSION; CONVERGENT VALIDITY; CORRELATION ANALYSIS; DEMOGRAPHY; EVALUATION AND FOLLOW UP; FEMALE; HOSPITALIZATION; HUMAN; INTERNAL CONSISTENCY; INTERRATER RELIABILITY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE ASSESSMENT; SCORING SYSTEM; STRAUSS CARPENTER SCALE; THE SHEEHAN DISABILITY SCALE; VALIDATION PROCESS;

EID: 85050483454     PISSN: None     EISSN: 21947511     Source Type: Journal    
DOI: 10.1186/s40345-016-0063-3     Document Type: Article

References (30)

1. Angst F, Stassen HH, Clayton PJ, Angst J. Mortality of patients with mood disorders: follow-up over 34–38 years. J Affect Disord. 2002;68:167–81.
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-IV). 4th ed. Washington-DC: APA; 1994.
3. Ahuir M, Bernardo M, de la Serna E, Ochoa S, Carlson J, Escartín G, et al. Adaptación y validación española de la Escala Pronóstica para la Esquizofrenia de Strauss y Carpenter. Revista de Psiquiatría y Salud Mental. 2009;2(4):150–9.
4. Barbeito S, Vega P, Ruiz de Azua S, Balanza-Martinez V, Colom F, Lorente E, et al. Integrated treatment of first episode psychosis with online training (e-learning): study protocol for a randomised controlled trial. Trials. 2014;15:416.
5. Bland JM, Altman DG. Cronbach’s alpha. BMJ. 1997;314:572.
6. Burdick KE, Goldberg JF, Harrow M. Neurocognitive dysfunction and psychosocial outcome in patients with bipolar I disorder at 15-year follow-up. Acta Psychiatr Scand. 2010;122(Suppl 6):499–506.
7. Castro-Fornieles J, Baeza I, de la Serna E, Gonzalez-Pinto A, Parellada M, Graell M, et al. Two-year diagnostic stability in early-onset first-episode psychosis. J Child Psychol Psychiatry. 2011;52(Suppl 10):1089–98.
8. Cotrena C, Branco LD, Shansis FM, Fonseca RP. Executive function impairments in depression and bipolar disorder: association with functional impairment and quality of life. J Affect Disord. 2015;190:744–53.
9. Endincott J, Spitzer RL, Fleiss JL, Cohen J. The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry. 1976;33:766–71.
10. Evensen J, Røssberg JI, Barder H, Haahr U, Wt Hegelstad, Joa I, et al. Apathy in first episode psychosis patients: a 10 year longitudinal follow-up study. Schizophr Res. 2012;136(Suppl 1–3):19–24.
11. Jiménez E, Arias B, Castellví P, Goikolea JM, Rosa AR, Fañanás L, et al. Impulsivity and functional impairment in bipolar disorder. J Affect Disord. 2012;136(Suppl 3):491–7.
12. Jordan G, Lutgens D, Joober R, Lepage M, Iyer SN, Malla A. The relative contribution of cognition and symptomatic remission to functional outcome following treatment of a first episode of psychosis. J Clin Psychiatry. 2014;75(Suppl 6):e566–72.
13. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51(1):8–19.
14. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):617–27.
15. Kessler RC, Petukhova M, Sampson NA, Zaslavsky AM, Wittchen H-U. Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States. Int J Methods Psychiatr Res. 2012;21(3):169–84.
16. Melle I, Friis S, Hauff E, Vaglum P. Social functioning of patients with schizophrenia in high-income welfare societies. Psychiatr Serv. 2000;51(Suppl 2):223–8.
17. Nieman DH, Velthorst E, Becker HE, de Haan L, Dingemans PM, Linszen DH, et al. The Strauss and Carpenter prognostic scale in subjects clinically at high risk of psychosis. Acta Psychiatr Scand. 2013;127(Suppl 1):53–61.
18. Parellada M, Castro-Fornieles J, Gonzalez-Pinto A, Pina-Camacho L, Moreno D, Rapado-Castro M, et al. Predictors of functional and clinical outcome in early-onset first-episode psychosis: the child and adolescent first episode of psychosis (CAFEPS) study. J Clin Psychiatry. 2015;76(Suppl 11):e1441–8.
19. Pinna M, Manchia M. Prognostic models in bipolar disorder: can the prediction of the long-term clinical course rely on the integration of clinical and molecular data? Biomark Med. 2014;8(Suppl 3):371–4.
20. Poirier S, Bureau V, Lehoux C, Bouchard RH, Maziade M, Pelletier S, et al. A factor analysis of the Strauss and Carpenter revised outcome criteria scale: a validation of the French translation. J Nerv Ment Dis. 2004;192(Suppl 12):864–7.
21. R Core Team R. A language and environment for statistical computing. R foundation for statistical computing, Vienna, Austria. 2014. URL http://www.R-project.org/.
22. Rosa AR, Sánchez-Moreno J, Martínez-Aran A, Salamero M, Torrent C, Reinares M, et al. Validity and reliability of the functioning assessment short test (FAST) in bipolar disorder. Clin Pract Epidemiol Ment Health. 2007;3:5.
23. Rosa AR, Franco C, Martinez-Aran A, Sanchez-Moreno J, Reinares M, Salamero M, et al. Functional impairment in patients with remitted bipolar disorder. Psychother Psychosom. 2008;77:390–2.
24. Samara MT, Engel RR, Millier A, Kandenwein J, Toumi M, Leucht S. Equipercentile linking of scales measuring functioning and symptoms: examining the GAF, SOFAS, CGI-S, and PANSS. Eur Neuropsychopharmacol. 2014;24(Suppl 11):1767–72.
25. Sheehan DV, Harnett-Sheehan K, Raj BA. The measurement of disability. Int Clin Psychopharmacol. 1996;11(Suppl 3):89–95.
26. Strauss JS, Carpenter WT Jr. The prediction of outcome in schizophrenia. I. Characteristics of outcome. Arch Gen Psychiatry. 1972;27(Suppl 6):739–46.
27. Strauss JS, Carpenter WT Jr. The prediction of outcome in schizophrenia. II. Relationships between predictor and outcome variables: a report from the WHO international pilot study of schizophrenia. Arch Gen Psychiatry. 1974;31(Suppl 1):37–42.
28. Suzuki T, Uchida H, Sakurai H, Ishizuki T, Tsunoda K, Takeuchi H, et al. Relationships between global assessment of functioning and other rating scales in clinical trials for schizophrenia. Psychiatry Res. 2015;227(Suppl 2–3):265–9.
29. Streiner DL. Starting at the beginning: an introduction to coefficient alpha and internal consistency. J Pers Assess. 2003;80(1):99–103.
30. Vieta E, Torrent C, Martínez-Arán A, Colom F, Reinares M, Benabarre A, et al. A user-friendly scale for the short and long term outcome of bipolar disorder: the CGI-BP-M. Actas Esp Psiquiatr. 2002;30(Suppl 5):301–4.